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Cells infected with certain temperature-sensitive mutants of Moloney murine
leukemia virus synthesize the virion precursor proteins but neither bud virions nor
cleave precursor proteins to their mature form. Addition of proteases to cells
infected with these mutants caused cleavage of the precursor proteins PrWag and
Prl80gag-pol to their mature forms at the nonpermissive temperature. Concomitant-
ly there was release from the cells of morphologically normal virions. The
enzymatically inactive Prl8Ogagpoi was cleaved to active reverse transcriptase
(p85), which was found in the released particles. External protease treatment
apparently bypassed the lesion in these viral mutants, suggesting that their defect
may involve a virus-specific protease.
Murine leukemia viruses (MuLV) can be
grown in fibroblast or lymphocyte tissue culture
lines where the virus is expressed chronically
and indefinitely without impairing cell growth
(for review, see references 4 and 11). The trans-
lation of the viral mRNAs produces polyprotein
precursors, which must undergo proteolytic
cleavages to be transformed into the mature
virion proteins (for review, see reference 11).
The cleavage steps occur mainly in precursors
that are associated with the plasma membrane of
the infected cells (21). It is at the plasma mem-
brane that gag, pol, and env proteins assemble
with virion RNA into a viral bud and eventually
into a complete virion (7, 18).
In chronically infected cell populations, the
assembly process is too asynchronous to study
biochemically or morphologically. Our under-
standing of retroviral maturation has therefore
come largely from an analysis of mutants condi-
tionally blocked in protein processing and virion
morphogenesis. Rauscher ts24 (R-ts24) and Mo-
loney ts3 (M-ts3) are the prototypes of such
MuLV mutants (12, 20). R-ts24, isolated after
nitrosoguanidine mutagenesis, and M-ts3, isolat-
ed as a spontaneous mutant, have virtually indis-
tinguishable phenotypes (18). Cells infected with
these mutants and maintained at the nonpermis-
sive temperature (39°C) release virtually no viri-
ons whether measured by assaying the culture
media for reverse transcriptase activity, infec-
tious virus, or viral proteins.
When cells infected by R-ts24 or M-ts3 are
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metabolically labeled at 39°C with [35S]methio-
nine and cellular lysates are analyzed electro-
phoretically, an intracellular accumulation of
gag and gag-pol precursors is seen (13, 14, 18).
The maturation block is very rapidly reversed
upon shifting the cultures to 32°C; prelabeled
precursors are then detected in extracellular
particles as mature virion proteins (18). Reverse
transcriptase activity is also found extracellular-
ly, and supernatant fluids are infectious. In fact,
the work of previous investigators and of this
laboratory has confirmed that harvests collected
only 30 min after temperature shift are infectious
(7; P. Traktman, unpublished results). In addi-
tion, the burst after the shifting of cultures to
32°C is fully induced even in the presence of
cycloheximide, a potent inhibitor of protein syn-
thesis (7, 18; P. Traktman, unpublished results).
The recovery of normal virus maturation can
apparently proceed solely with components syn-
thesized at 39°C. To date, no agreement has
been reached on the identity of the lesion in
these mutants. Although a defect in one of the
precursors which precludes maturation has been
suggested, the defect may as well reside in the
cleavage itself, perhaps in a possible viral prote-
ase. In this paper, we present evidence that the
addition of extracellular protease at 39°C to
these infected cells causes a rapid release of the
block in viral assembly.
MATERIALS AND METHODS
Viruses and cells. R-ts24 was supplied by S. Aaron-
son, National Cancer Institute. The viruses were
grown in NIH/3T3 cells, usually in cell lines derived by
low-multiplicity infection and immediate cloning. To
construct such clones, NIH/3T3 cells were infected
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with the virus at a multiplicity of 0.3 and then seeded
in 96-well microtiter trays at a density of 0.3 cells per
well. Infected clones were identified by assaying the
culture medium for reverse transcriptase activity, in-
fectious virus, or viral proteins. Two of these clonal
lines, 3N7 and 24N3, have been previously described
(18). The cells were maintained in Dulbecco modified
Eagle medium (DME) supplemented with 10% calf
serum and buffered with CO2 and were passaged at
37°C except where noted in the text.
Titers of infectious virus were determined by the XC
plaque assay (10). Assays were performed at 32, 37, or
39°C as necessary.
All viral infections were done in the presence of 8 p.g
of Polybrene per ml (Aldrich Chemical Co.) to en-
hance adsorption. Polybrene was sometimes included
in the growth medium for several days at 2 ,ug/ml to
enhance viral spread. Viral harvests were collected 12
to 18 h after medium change, except where otherwise
indicated, and filtered through 0.45-p.m filters before
use.
Metabolic labeling. For metabolic labeling of cell
proteins, monolayers were washed twice with phos-
phate-buffered saline (PBS) and labeled with
[35S]methionine (New England Nuclear Corp.) in se-
rum-free DME lacking methionine. Labelings were
routinely performed with 50 p.Ci/ml and varied in
duration from 40 min to 4 h, as described below.
Chases were performed by adding prewarmed com-
plete DME plus serum, with or without removal of the
labeling medium.
For preparation of overnight harvests of virus with
metabolically labeled proteins, monolayers in 10-cm
dishes were washed and then labeled with 125 ,uCi of
[35S]methionine in 4 ml of methionine-free DME sup-
plemented with 2% DME and 10% dialyzed fetal calf
serum. The medium was collected after 10 to 16 h and
processed as described below.
Virus purification. Culture fluids from virus-infected
lines were collected and filtered through 0.45-p.m
filters or centrifuged at 1,200 rpm for 10 min to remove
cells. The virus was then layered on discontinuous
gradients of 25 and 45% sucrose in PBS. After ultra-
centrifugation for 2.5 to 3 h at 22,000 to 30,000 rpm,
the interface was collected and diluted with PBS, and
the virus subsequently was collected by sedimentation
at 38,000 to 45,000 rpm for 1 to 3 h.
Reverse transcriptase assay. Supernatant fluids were
either assayed directly or first concentrated (typically
40-fold) by ultracentrifugation at 38,000 to 45,000 rpm
for 1 to 2 h. Virus pellets were suspended in 20 mM
Tris (pH 8.3) and disrupted with detergent, and the
exogenous activity was assayed by using a polyribo-
adenylate template and oligodeoxythymidylate primer
as described (8). Enzyme activity was quantitated by
measuring incorporation of [3H]TTP into trichloroace-
tic acid-precipitable material.
Protease treatment of intact cells. Subconfluent cul-
tures of infected NIH/3T3 cells were rinsed twice with
DME and then treated with proteases appropriately
diluted in 2 to 2.5 ml of DME (or, less frequently, in
Hanks balanced salt solution). Several preparations of
trypsin were used: partially purified hog pancreas
extract used for passaging tissue culture cells (GIBCO
Laboratories), trypsin-tolylsulfonyl phenyalanyl
chloromethyl ketone (Worthington Diagnostics), and
3X crystallized trypsin (Worthington). Thermolysin
(Calbiochem), papain (Sigma Chemical Co.), plasmin
(Sigma), and a-chymotrypsin (Worthington) were also
used. The concentrations (routinely 2 to 50 ,ug/ml) and
duration of protease treatment are described below.
Reactions were stopped by rapid chilling and the
addition of one of the following: N-a-p-tosyl-L-lysine
chloromethyl ketone (TLCK; Calbiochem), phenyl-
methylsulfonyl fluoride (Sigma), soybean trypsin in-
hibitor (Calbiochem), bovine serum albumin (Pentex,
Miles Laboratories), or calf serum. After treatment,
cells were usually detached or only loosely adherent
and easily removable from the culture dishes. Control
cells were gently scraped from the culture dishes. For
further analysis, cells and fluid were either analyzed
together or first separated by centrifugation at 2,000
rpm for 10 min at 4°C.
Immune precipitations. To analyze the proteins of
metabolically labeled cells, cultures were lysed on ice
in a lysis buffer containing sodium dodecyl sulfate,
deoxycholate, and Triton X-100 as previously de-
scribed (18). Cell lysates, prepared at 106 cells per ml,
were clarified by centrifugation at 1,200 rpm for 10 min
and then precleared by incubation with normal serum
and fixed Staphylococcus aureus (The Enzyme Cen-
ter, Tufts Medical Center) followed by a 1- to 3-h
centrifugation at 35,000 to 45,000 rpm at 4°C (5). 35S-
labeled virions were lysed with the appropriate con-
centration of the same phospholysis buffer to give the
same final conditions.
Samples were immunoprecipitated with 1 to 5 ,u1 of
the appropriate antiserum overnight at 4°C. Sera were
either previously prepared in this laboratory (18) or
were kindly supplied by Roger Wilsnack, National
Cancer Institute. Fixed S. aureus (25 p.1 of a 10%
stock) was then added, and incubation was allowed to
proceed for at least 1 h on ice (5). The immune
precipitates were collected by centrifugation and
washed twice with lysis buffer. The final S. aureus
pellets were suspended in sample buffer, containing
sodium dodecyl sulfate, 2-mercaptoethanol, glycerol,
and dye, and then boiled or heated at 68°C. The S.
aureus was removed by centrifugation, and the super-
natants were analyzed by electrophoresis through so-
dium dodecyl sulfate-polyacrylamide slab gels, as de-
scribed below.
Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis. Discontinuous polyacrylamide slab gels were
used as described (6). Gels of 10% acrylamide and
exponential gradient gels of 5 to 20% and 10 to 20%
acrylamide were used most commonly. After staining
and fixation, gels were either dried driectly or first
treated for fluorography with dimethyl sulfoxide-2,5-
diphenyloxazole (1) or with 1 M sodium salicylate.
They were then exposed to XR5 X-ray film.
Electron microscopy of cells and virus. Cells were
processed either as pellets or as adherent monolayers.
As indicated below, they were sometimes washed with
PBS or cacodylate buffer before fixation with 2%
glutaraldehyde for 30 to 60 min at the temperature
indicated in the text. They were then washed with PBS
or cacodylate buffer, postfixed with osmium tetroxide,
stained with uranyl acetate, and dehydrated in a
graded series of alcohols. Samples were then embed-
ded in an epon-araldite-dodecenylsuccinic anhydride
resin. Thin sections were examined on a Philips 201
microscope after poststaining with uranyl acetate and
lead citrate.
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RESULTS
Cleavage of Pr659'9 in R-ts24-infected cells at
the nonpermissive temperature. The processing
of the gag precursor, Pr659ar, occurs poorly, if
at all, in cells infected with either R-ts24 or M-
ts3 and maintained at 39°C (13, 14, 18). To
examine whether the addition of external prote-
ase to intact cells could initiate proteolytic proc-
essing, proteins from treated and untreated cells
were analyzed by electrophoresis of [35S]meth-
ionine-labeled cell extracts that had been
immunoprecipitated with appropriate sera. R-
ts24-infected cells were grown at 32°C (permis-
sive temperature), shifted to 39°C (restrictive
temperature), and metabolically labeled for 4 h
with [35S]methionine. The cells were chased at
39°C with fresh 39°C serum-free medium for up
to 20 min with or without added trypsin and then
rapidly chilled and lysed. In the absence of
protease, only Pr65gag and Pr55gag (a product of
Pr65 cleavage) were precipitated from the cell
lysate by anti-p30 serum; virtually no labeled
protein was released into the medium (Fig. 1,
lanes Al and A2). If cells similarly labeled at
39°C were instead shifted to 32°C for the 20 min
chase, Pr65, Pr55, Pr4O (another gag-related
cleavage product), and mature p30 were seen in
the cells and in virions recovered from the
medium (Fig. 1, lanes Dl and D2). The majority
of the immunoreactive protein was in virions.
When cells were exposed to 20 ,ug of trypsin per
ml during a 5-min chase in 39°C serum-free
medium, two new polypeptides (30,000 to 45,000
molecular weight) became evident in the cells,
but not the medium, by immunoprecipitation
with anti-p30 serum (Fig. 1, lanes Bl and B2). If
this 5-min treatment was followed by the addi-
tion of soybean trypsin inhibitor and a further
15-min chase at 39°C, these new polypeptides
were decreased in yield and p30 was recovered
from the cells and the supernatant (Fig. 1, lanes
Cl and C2).
Great care was taken to standardize the tech-
nical details of this experiment because of the
hazard of an accidental shift-down of tempera-
ture with these temperature-sensitive mutants.
Passage schedule and cell density were uniform.
All treatments were done in DME equilibrated
with CO2 to maintain the pH. Manipulations of
39°C cultures were performed on a warm tray in
a warm room with prewarmed reagents. Under
these conditions, there was little difficulty in
maintaining the fully restrictive conditions
throughout the 39°C experiments as measured
by the absence of released reverse transcriptase-
containing particles in the medium of control
39°C cultures.
External trypsin treatment of the cells ap-
peared to be triggering the cleavage of Pr65
and the pathway to p30 was being completed
even after trypsin activity was inhibited. Several
preparations of trypsin, including that routinely
used for passaging cells, had the same effect.
The extent of cleavage of Pr659ar varied with the
concentration of the trypsin (Fig. 2, lanes C2,
D2, E2). The cleavage was at least partly specif-
ic for gag, as no change was seen in the env
protein (Fig. 2, lanes Cl, Dl, El). This lack of
effect of trypsin treatment on the env product
was also seen when R-ts24-infected fibroblasts
were stained with env-specific antiserum and
fluoresceinated antibody to immunoglobulin G
and examined microscopically. The intensity of
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FIG. 1. Cleavage of Pr5gag after treatment of in-
tact cells with trypsin. R-ts24-infected 24N3 cells were
seeded at 1.5 x 106 per 10-cm dish and grown for 2
days at 39°C. Cells were labeled for 4 h at 39°C in
methionine-free DME supplemented with 100 ,Ci of
[35S]methionine. The labeling media were then dis-
carded, cultures were rinsed with serum-free medium,
and they were then incubated in fresh medium for an
additional time under various conditions: (A) 20 min at
39°C, DME; (B) 5 min at 39°C, DME with 20 ,ug of
trypsin per ml; (C) 5 min at 39°C, DME with 20 ,Lg of
trypsin per ml followed by 15 min at 39°C in the
presence of 100 ,ug of soybean trypsin inhibitor per ml;
(D) 20 min at 32°C, DME. The cultures were then
rapidly chilled, and soybean trypsin inhibitor was
added to 20 ,ug/ml. Media (lanes labeled 1) and cells
(lanes labeled 2) were separately harvested, diluted
with phospholysis buffer, and immune precipitated
with anti-gag antiserum. Immunoprecipitates were
analyzed by electrophoresis through a 10% polyacryl-
amide gel.
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FIG. 2. Trypsin-induced cleavage of Pr659aB is specific and concentration dependent. R-ts24-infected 24N3
cells were seeded at 1.5 x 106 per 10-cm dish and grown for 2 days at 39°C. Cells were then labeled for 2 h at 39°C
in methionine-free DME supplemented with 100 ,uCi of [35S]methionine per ml, complete DME was added, and
cells were incubated for a further 2 h. The labeling medium was discarded, the cells were washed twice, and then
they were incubated for 5 min under various conditions: (A) 39°C, PBS; (B) 39°C, PBS supplemented with 200 jig
of trypsin per ml and 1 mM TLCK; (C) 39°C, PBS supplemented with 200 ,ug of trypsin per ml; (D) 39°C, PBS
supplemented with 20 pLg of trypsin per ml; (E) 39°C, PBS supplemented with 2 ,ug of trypsin per ml. The cells
were then treated with 1 mM TLCK, rapidly chilled, lysed, and immunoprecipitated with (lanes labeled 1) anti-
env or (lanes labeled 2) anti-gag antisera. Samples were analyzed on a 5- to -20% polyacrylamide gel.
membrane fluorescence was equivalent in con-
trol and trypsinized cells (data not shown).
Prior incubation of the trypsin with TLCK (a
potent inhibitor of trypsin) blocked the gag
cleavage (Fig. 2, lane B2). Incubations of 20 min
at 39°C in the presence of increasing concentra-
tions of trypsin gave higher intracellular yields
of the new intermediates and p30. A greater
yield of p30 in released particles was achieved,
however, with milder and shorter treatments,
implying that trypsin can damage the ability to
release buds but still cause cleavage of the gag
precursor proteins (data not shown).
The new gag gene intermediates appearing in
the trypsin-treated cells corresponded to inter-
mediates seen at very early times after shift-
down of cultures to 32°C (data not shown; these
bands are not apparent in Fig. 1, which displays
the profile at 20 min after shift-down). The
trypsin-induced pattern was thus consistent with
physiological cleavage of the Pr65gag precursor.
A similar induction of Pr65gag cleavage at
39°C was also seen after treatment with chymo-
trypsin and thermolysin (but not with plasmin).
The pattern of bands precipitated with anti-p30
serum was similar to that seen after trypsiniza-
tion, although the relative intensities of the new
bands were variable (data not shown). Trypsin
cleaves after basic residues (lysine and argi-
nine), chymotrypsin cleaves after aromatic resi-
dues (phenylalanine and tryptophan), and the
specificity of thermolysin is not well character-
ized. Pr659'9 may present highly susceptible
sites which can be cleaved by a variety of
proteases, but the effectiveness of three dissimi-
lar enzymes in inducing this cleavage makes it as
likely that the added enzyme is inducing Pr659'9
cleavage indirectly. Activation of a second en-
zyme, or an indirect effect on a structural ele-
ment, are likely mechanisms for this phenome-
non.
Pr809ga9Po cleavage in R-ts24-infected cells at
the nonpermissive temperature. Mature reverse
transcriptase, p85, is derived by cleavage from a
180,000-dalton gag-pol precursor, with interme-
diates of 130,000 and 145,000 daltons; significant
cleavage to p85 occurs only after virions have
been released (18). Polymerase activity has been
J. VIROL.
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FIG. 3. Effect of trypsin treatment on gag-pol mat-
uration. R-ts24-infected 24N3 cells were seeded at 1.5
x 106 per 10-cm dish and grown for 2 days at 39°C.
Cells were then labeled for 4 h at 39°C in methionine-
free DME with 50 ,uCi of [35S]methionine per ml. Cells
were then washed and incubated for an additional 30
min at 39°C after being refed with (A) DME, or (B)
DME with 20 pLg of trypsin per ml. Cells were lysed
and immune precipitated with (lanes labeled 1) anti-
env or (lanes labeled 2) anti-pol sera. Samples were
analyzed on a 5 to 20% polyacrylamide gel.
detected in the mature p85 but not in the precur-
sor or intermediate molecules (18). To examine
Pri80gag-pol processing after protease treatment,
R-ts24-infected cultures were shifted to 39°C and
labeled for 4 h with [35S]methionine. Cells were
chased for 20 min at 39°C in fresh, unlabeled
39°C medium and then rapidly chilled and lysed.
Intracellular polypeptides of molecular weight
180,000, 145,000, and 130,000 were precipitated
with anti-reverse transcriptase serum (Fig. 3,
lane A2). If a 20-min chase was performed with
fresh medium containing trypsin, additional
polypeptides were precipitated: a doublet with a
molecular weight of approximately 100,000 and
a band comigrating with mature reverse tran-
scriptase at 85,000 daltons (Fig. 3, lane B2).
Trypsinization apparently relieved blocks to
both Pr659'9 and Prl80gagVPoI cleavage in R-ts24-
infected cells at 39°C.
Release of sedimentable reverse transcriptase
activity. To examine the appearance of enzymat-
ically active reverse transcriptase and the state
of the viral proteins released upon trypsin treat-
ment, we examined the supernatants of trypsin-
treated cells for virions as measured by sedimen-
table reverse transcriptase activity. R-ts24-
infected cells were shifted to 39°C for 4 h, the
medium was changed, and the cells were either
maintained at 39°C or shifted to 32°C. After 30 or
60 min, supernatants were chilled, and the parti-
cles sedimented by ultracentrifugation were as-
sayed for reverse transcriptase activity. The
39°C collections repeatedly had low or back-
ground enzymatic activity. Cultures shifted to
32°C released a burst of virus, and enzyme
assays often showed a 50-fold increase in re-
verse transcriptase activity above the 39°C con-
trol (Table 1). If the cultures were maintained at
39°C but the 30- or 60-min incubations were
done in the presence of trypsin, high levels of
reverse transcriptase were found in the superna-
tants (Table 1). Culture fluids collected in the
presence of 5 ,ug of trypsin per ml had more
enzyme activity than those treated with 20 ,ug of
trypsin per ml. Both chymotrypsin and thermo-
lysin were effective in increasing the level of
release of reverse transcriptase-containing parti-
cles (Table 1).
In all experiments, comparable positive re-
sults were found in trypsin-treated cultures and
cultures shifted to 32°C, but the magnitude of the
released bursts varied. Attempts to standardize
variables of pH, cell density, and cell passage
TABLE 1. Effect of temperature and protease
treatment on reverse transcriptase release by R-ts24-
infected cells
Reverse transcriptase activity
Treatment of (cpm x 103)b
Expt 1 Expt 2 Expt 3 Expt 4
Maintained at 7.0 0.8 2.0 0.5
390C
Maintained at 114.1 41.6 5.3
390C, with 20
,ug of trypsin
per ml
Maintained at 16.9 6.2
39°C, with 20
,ug of
thermolysin
per ml
Maintained at 2.9
39°C, with 20
,ug of
chymotrypsin
per ml
Shifted to 320C 138.2 94.0 9.8 4.7
a 24N3 cells were seeded at 1.5 x 106 per 10-cm dish
and grown for 2 days at 39°C. The cultures were then
rinsed and refed with prewarmed DME and incubated
for an additional 30 min under the conditions described
above.
b The freshly added medium was harvested after 30
min and rapidly chilled. The virions were purified by
sedimentation and then assayed for reverse transcrip-
tase activity by using exogenously added template and
primer, as described in the text. Activity was moni-
tored by measuring the incorporation of [3H]TTP into
acid-precipitable material.
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schedule did not eliminate the variablity in elicit-
ing virion release.
Morphology of R-ts24-infected cells. The mor-
phology of cultures infected with these tempera-
ture-sensitive mutants and maintained at 39°C
has previously been studied (2, 18, 19, 21). The
number of viral buds observed has been shown
to vary with several parameters, including
whether cultures are washed with buffer before
fixation and the time elapsed between seeding
the cultures and their fixation. With these points
in mind, when we compared the morphologies of
R-ts24-infected 24N3 cultures maintained at
39°C, shifted briefly to 32°C, or treated with
protease at 39°C, all conditions were maintained
as constant as possible. Importantly, all cultures
were rinsed an equal number of times with
growth medium whether they were treated with
enzyme or not. Cultures held at 39°C displayed
large numbers of late-stage buds on the cell
membrane and very few complete, extracellular
virions (Fig. 4A). In cultures shifted to 32°C for
30 min, the number of buds was far lower, and
the number of free virions associated with the
cell pellet was greatly increased (Fig. 4C). Cul-
tures treated at 39°C with trypsin for 30 min had
many floating or only loosely adherent cells. The
cells were viable, however, and displayed a
large number of processes. Buds were still evi-
dent on the outer cell membrane, but many free
particles indistinguishable from virions were
also observed (Fig. 4B). Most particles had the
collapsed structure which correlates with ma-
ture gag proteins, rather than the sharp concen-
tric ring characteristic of buds and immature
particles. In other experiments, culture fluids
were subjected to ultracentrifugation, and the
trypsin-induced release from cells of particles
with mature virion morphology was demonstrat-
ed.
DISCUSSION
In cells infected with the temperature-sensi-
tive mutants R-ts24 and M-ts3, the coupled
processes of proteolytic cleavage of precursors
to mature proteins and virion release are
blocked at 39°C. We showed that protease added
externally to intact cells can mimic the effect of a
shift to 32°C, phenotypically bypassing the tem-
perature-sensitive block. Trypsin induced cleav-
age of Pr65gag to several intermediates and p30,
and of Pr1809'9-P° to intermediates and p85 at
the nonpermissive temperature. We recovered
sedimentable material from the supernatants of
protease-treated, 39°C cultures with high levels
of reverse transcriptase activity. Particles indis-
tinguishable from virions were seen in the elec-
tron microscope in cultures treated with prote-
ase at 39°C. Protease treatment destroyed the
infectivity of authentic virions, and therefore the
infectivity of protease-induced particles could
not be tested.
It seems unlikely that trypsin, thermolysin,
and chymotrypsin, with molecular weights near
25,000, enter the cells to cause these effects.
Rather, the enzymes probably act on the exteri-
or surface of the cells. Because these three
enzymes with very different specificities have
such similar effects and may act from outside,
mechanisms other than direct cleavage of
Pr659'9 or Pr1809'"" should be considered.
Among the possible defects in these tempera-
ture-sensitive mutants is a structural error in
assembly at 39°C that prevents the precursors
from assuming the spatial arrangement neces-
sary to initiate bud release and protein cleavage.
Trypsin might then be acting to release a
"stress" in configuration of the 39°C bud, allow-
ing maturation to proceed normally. This could
occur by cleavage of proteins on the cell surface
or of structural elements within the membrane.
Trypsin causes 24N3 cells to detach from the
culture dish surface and round up, and the
consequent changes in cytoskeletal structure
might affect the bud configuration. This sugges-
tion predicts that other agents affecting cell
shape might have a similar effect on virus matu-
ration. Cytochalasin, a cytoskeletal disrupter,
did not, however, have an effect like that of
trypsin, although the cells were made to round
up and float (data not shown). Hypo- or hyper-
tonicity also appeared to be ineffective in releas-
ing the temperature-sensitive block (data not
shown). These mutants are also temperature-
sensitive in lymphoid cells which naturally grow
as nonadherent cells (data not shown). We
therefore consider it unlikely that the proteases
act through such effects.
Another possible explanation of these mor-
phogenetic mutants is that they could have a
defect in one of the polyproteins that prevents
its cleavage. It could be, for instance, a protease
precursor which, in its mutant form, cannot
begin a cascade of proteolysis. External prote-
ase treatment might somehow cleave an accessi-
ble bond and begin a cascade leading to a full
complement of cleaved proteins. It is also possi-
ble that the mutants make a protease that is
temperature sensitive in its activity, but it is not
clear how an externally applied protease could
produce all of the cleavages needed to form
complete virion-like particles containing active
reverse transcriptase.
The enzymes of cellular or viral origin that are
responsible for these viral cleavages are as yet
unknown. In the avian retroviral system, a viral-
ly coded thiol protease (p15) has been implicated
in viral maturation (3, 9, 15). In the murine
system, there have been reports of a 24,000-
molecular-weight serine protease recoverable in
J. VIROL.
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FIG. 4. Electron micrographs of R-ts24-infected 24N3 cells. R-ts24-infected 24N3 cells were seeded at 1.5 x
106 per 10-cm dish and grown at 39°C for 2 days. The cultures were then refed and incubated for an additional 20
min under the following conditions: (A) 39°C, DME (x 70,000); (8) 39°C, DME at 20 ,ug of trypsin per ml (x
30,000); (C) 32°C, DME (x 30,000). Cultures were then rinsed with buffer, fixed, and embedded. Representative
micrographs are shown.
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extremely low yield from virions (22-24; R.
Luftig, personal communication). This activity
appears to cleave Pr659'9 accurately. It is inter-
esting to note that the proteases with activity in
the experiments described here are largely ser-
ine proteases and may have a similarity to the
physiological protease in the murine system.
There are precedents in the literature for
profound effects on cellular events mediated by
external proteases. For instance, activation of
membrane-bound adenyl cyclase by external
trypsin has been demonstrated (16), and protease
treatment can induce cells to produce and se-
crete collagenase and plasminogen activator
(17). How the effects we have noted or the
effects previously demonstrated are produced
by an external protease remains an intriguing
puzzle.
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